COCP
Cocrystal Pharma, Inc.NASDAQHealthcare$1.51-0.66%ClosedMarket Cap: $15.5M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.67
P/S
0.00
EV/EBITDA
-1.14
DCF Value
$0.47
FCF Yield
-54.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-132.6%
ROA
-90.9%
ROIC
-115.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | Infinity% | $-2.5M | $-2.4M | $-0.16 | — |
| FY 2025 | $0.00 | NaN% | $-9.0M | $-8.8M | $-0.78 | — |
| Q3 2025 | $0.00 | -Infinity% | $-2.1M | $-2.0M | $-0.19 | — |
| Q2 2025 | $0.00 | -Infinity% | $-2.1M | $-2.1M | $-0.20 | — |
| Q1 2025 | $0.00 | -Infinity% | $-2.3M | $-2.3M | $-0.23 | — |
| Q4 2024 | $0.00 | -Infinity% | $-3.2M | $-3.3M | $-0.32 | — |
| FY 2024 | $0.00 | -Infinity% | $-17.9M | $-17.5M | $-1.72 | — |
| Q3 2024 | $0.00 | -Infinity% | $-5.0M | $-4.9M | $-0.49 | — |
| Q2 2024 | $0.00 | -Infinity% | $-5.4M | $-5.3M | $-0.53 | — |
| Q1 2024 | $0.00 | -Infinity% | $-4.2M | $-4.0M | $-0.39 | — |
| Q4 2023 | $0.00 | -Infinity% | $-4.7M | $-4.5M | $-0.44 | — |
| FY 2023 | $0.00 | -Infinity% | $-18.6M | $-18.0M | $-0.00 | — |